LC-MS/MS raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-10-27 and is reviewed periodically as new material appears.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
Ancient Greek physicians Galen (c. 130–200) and Hippocrates (c. 400 BC) as well as Sumerian clay tablets dating from 2150 BC that advocate the use of similar techniques. Florence Nightingale, who contributed substantially to the report of the Royal Commission on the Health of the Army (1856–1857), based on her earlier work Medieval surgeons Hugh of Lucca, Theoderic of Servia, and his pupil Henri de Mondeville were opponents of Galen's opinion that pus was important to healing, which had led ancient and medieval surgeons to let pus remain in wounds. They advocated draining and cleaning the wound edges with wine, dressing the wound after suturing (if necessary), and leaving the dressing on for ten days, soaking it in warm wine all the while, before changing it. Their theories were bitterly opposed by Galenist Guy de Chauliac and others trained in the classical tradition. Oliver Wendell Holmes Sr., who published The Contagiousness of Puerperal Fever in 1843
=== OpenTag === DASH7 Mode 2 developers benefit from the open-source firmware library called OpenTag, which provides developers with a "C"-based environment in which to develop DASH7 applications quickly. So in addition to DASH7 (ISO 18000-7) being an open source, ISO standard, OpenTag is an open-source stack that is quite unlike other wireless sensor networking (e.g. ZigBee) and active RFID (e.g. proprietary) options elsewhere in the marketplace today. Even though OpenTag is an open-source project, people may not be able to use it free of charge. As of August 2015, there is no evidence to suggest that OpenTag bears a royalty, although current versions of OpenTag license Archived 2013-12-31 at the Wayback Machine do include a provision permitting RAND licensing.
==== Entertainment industry ==== Glycerol is used by set decorators when filming scenes involving water to prevent an area meant to look wet from drying out too quickly. Glycerine is also used in the generation of theatrical smoke and fog as a component of the fluid used in fog machines as a replacement for glycol, which has been shown to be an irritant if exposure is prolonged.
The situation in which a treatment contrast (e.g. difference between investigational product and control) is dependent on another factor (e.g. centre). A quantitative interaction refers to the case where the magnitude of the contrast differs at the different levels of the factor, whereas for a qualitative interaction the direction of the contrast differs for at least one level of the factor. (ICH E9) Inter-rater reliability
=== Missouri Senate (2009–2017) === On November 4, 2008, Schmitt was elected to the Missouri Senate. He represented the 15th district, which includes parts of central and western St. Louis County. Following the 2010 census, Schmitt's district was redrawn, but still centered around central St. Louis County. Schmitt ran unopposed in both the primary and general elections in 2012. In 2016, Schmitt sponsored S.B. 572, which set a limit on the percent of revenue that Missouri local governments could obtain from non-traffic fines (such as fines for violation of city ordinances). The bill passed the state Senate in a 25–6 vote in January 2016. After the Ferguson unrest, Schmitt said that too many municipalities overrelied on fines to raise revenue and fund their budgets. He led the bipartisan legislative effort to bar cities, counties and law-enforcement agencies from setting traffic-ticket quotas. Schmitt worked with Senator Jamilah Nasheed and others on the legislation, which passed the State Senate in February 2016 and was enacted into law. In 2010, Schmitt, who has a son with autism, supported a bill in the Missouri General Assembly that required health insurers to pay up to $40,000 annually to beneficiaries for applied behavioral analysis, a type of autism therapy. In 2015, he worked to enact legislation allowing Missouri residents to establish tax-exempt savings accounts for relatives with disabilities. Governor Jay Nixon signed the bill in 2015. In the State Senate, Schmitt championed tax-cut legislation. He sponsored a major franchise tax cut, which passed.
Sources: en.wikipedia.org
=== Additional evidence and deaths === A review of ephedra-related adverse reactions, published in the New England Journal of Medicine in 2000, found a number of cases of sudden cardiac death or severe disability resulting from ephedra use, many of which occurred in young adults using ephedra in the labeled dosages. Subsequently, in response to pressure from the consumer advocacy group Public Citizen, Metabolife was compelled by the Department of Justice in 2002 to turn over reports of over 15,000 ephedra-related adverse events, ranging from insomnia to death, which the company had previously withheld from the FDA. Use of ephedra was considered to have possibly contributed to the death of Minnesota Vikings offensive lineman Korey Stringer from heatstroke in 2001. Steve Bechler, a pitcher for the Baltimore Orioles, died of complications from heatstroke following a spring training workout on February 17, 2003. The medical examiner found that ephedra toxicity played a "significant role" in Bechler's sudden death. Following Bechler's death, the FDA re-opened its efforts to regulate ephedra use. According to Bruce Silverglade, legal director for the Center for Science in the Public Interest, "All of a sudden [after Bechler's death] Congress dropped objections to an ephedra ban and started demanding that the FDA act." Senator Orrin Hatch (R. Utah), who in 1999 had helped block the FDA's attempts to regulate ephedra, said in March 2003 that "...it has been obvious to even the most casual observer that problems exist", and called FDA action to regulate ephedra "long overdue."
The SPGB has a longstanding position that it is "opposed to a reform programme and to reformist organisations, but not opposed to reforms as such". Hence, the party does not campaign for reforms itself since its sole object is the establishment of socialism, but it is not opposed to reforms passed by the government when they are clearly in the interests of the working class. The Socialist Studies group disagrees with this position, explicitly stating that socialist Members of Parliament should vote against reform measures even when they are in the interests of the working class. The SPGB considers Socialist Studies's position on how socialist Members of Parliament should vote to be "a legitimate position for a socialist to hold, even though it is not the one that, as a matter of historical fact, has been adopted by the SPGB" and "do[es] not regard it as a matter for serious dispute".
The legislative branch of government is a unicameral legislative assembly, whose tenure is five years. The legislative assembly may make laws for any of the matters in the State List of the Constitution of India except "public order" and "police", which will remain the preserve of the central Government of India. The Lieutenant Governor also has the power to promulgate ordinances which have the same force as the acts of the legislative assembly. Elections for the Jammu and Kashmir Legislative Assembly were held in September and October 2024.
In science, a poison is any chemical substance that is harmful or lethal to a living organism. The term of poison is used in a wide range of scientific fields and industries, where it is often specifically defined. It may also be applied colloquially or figuratively, with a broad sense. The symptoms and effects of poisoning in humans can mimic those of other medical conditions and vary depending on the type of poison and the system of the body affected. Common symptoms include alterations in consciousness, abnormal body temperature, irregular heart rate, and changes in respiration. The severity and specific presentation of symptoms often depend on the nature and dose of the poison involved. Certain poisons, particularly caustic or irritating substances, can cause direct injury to mucous membranes in the mouth, throat, gastrointestinal tract, and lungs. These injuries may result in symptoms such as pain, coughing, vomiting, and shortness of breath. The term poisoning refers to the harmful physiological effects that result from the exposure to a toxic substance, typically through ingestion, inhalation, injection, or skin absorption. It is derived from the word poison and is commonly used in medical, biochemical, and toxicological contexts to describe adverse interactions between a substance and a living organism. Poisoning is sometimes used as a method of self-harm and of suicide, particularly in cases of intentional self-poisoning among individuals experiencing suicidal ideation.
=== Kl--Ku === Martin Heinrich Klaproth (1743–1817), German chemist, who discovered uranium and zirconium, and contributed to the discovery of other elements Trevor Kletz (1922–2013), British promoter of industrial safety Aaron Klug (1926–2018), winner of the 1982 Nobel Prize in Chemistry for developing crystallographic electron microscopy Emil Knoevenagel (1865–1921) German organic chemist, known for the condensation reaction of carbonyl compounds with active methylene compounds Jeremy Randall Knowles (1935–2008), British physical organic chemist known for studies of chemical mechanisms, especially in enzyme catalysis William Standish Knowles (1917–2012), 2001 Nobel Prize in Chemistry for work on asymmetric synthesis, specifically in hydrogenation reactions Walter Kohn (1923–2016), 1998 Nobel Prize in Chemistry for contributions to the understanding of the electronic properties of materials Adolph Wilhelm Hermann Kolbe (1818–1884), German chemist known for Kolbe nitrile synthesis Izaak Kolthoff (1894–1993), Dutch-American chemist with abundant published research in diverse fields of analysis, the "Father of Analytical Chemistry" Arthur Kornberg (1918–2007), American biochemist, Nobel Prize in Chemistry (1959) for discovery of DNA polymerase Hans Kornberg (1928–2019), British biochemist known for research in microbial biochemistry Roger D. Kornberg (born 1947), 2006 Nobel Prize in Chemistry for elucidation of how genetic information from DNA is copied to RNA Teresa Kowalska (1946–2023), Polish chemist, specialized in the theory and application of chromatography Hans A.
Sources: en.wikipedia.org
The pores permitted cationss transport after short oxidation periods, consistent with electrostatic repulsion from negatively charged functional groups at pore edges. After longer oxidation periods, sheets were permeable to salt but not larger organic molecules. In 2015, a team fabricated a graphene oxide home water purification system resembling a "tea bag" that, over the course of a day, can remove 95% of heavy metals when immersed in a drinking-water pot. A composite comprising small NiFe2O4 ferrimagnetic nanoparticles and partially reduced graphene oxide functionalized with nitrogen atoms was successfully used to remove Cr(III) ions from water. The advantage of this nanocomposite is that it can be magnetically separated from water. One project layered carbon atoms in a honeycomb structure, forming a hexagon-shaped crystal that measured about 0.1 millimeters in width and length, with subnanometer holes. Later work increased the membrane size to on the order of several millimeters. Graphene attached to a polycarbonate support structure was initially effective at removing salt. However, defects formed in the graphene. Filling larger defects with nylon and small defects with hafnium metal, followed by a layer of oxide, restored the filtration effect. In 2016, engineers developed graphene-based films powered by the sun that can filter dirty/salty water. Bacteria were used to produce a material consisting of two nanocellulose layers. The lower layer contains pristine cellulose, while the top layer contains cellulose and graphene oxide, which absorb sunlight and produce heat.
=== Fourier transform === The interferogram in practice consists of a set of intensities measured for discrete values of OPD. The difference between successive OPD values is constant. Thus, a discrete Fourier transform is needed. The fast Fourier transform (FFT) algorithm is used.
=== 250Cm === Curium-250 is the isotope with the lowest atomic number that primarily decays by spontaneous fission, a process that releases many times more energy than alpha decay. Compared to plutonium-238, curium-250 has about a quarter of the power density, but 95 times the half-life (~8300 years vs. ~87 years). As it is a neutron emitter (weaker than californium-252 but not negligible) some applications require a further shielding against neutron radiation. As lead, which is an excellent shielding material against gamma rays and beta ray induced Bremsstrahlung, is not a good neutron shield (instead reflecting most of them), a different shielding material would have to be added in applications where neutrons are a concern.
Three basic battery types are used in 2020s-era electric vehicles: cylindrical cells (e.g., Tesla), prismatic pouch (e.g., from LG), and prismatic can cells (e.g., from LG, Samsung, Panasonic, and others). Lithium-ion flow batteries have been demonstrated that suspend the cathode or anode material in an aqueous or organic solution. As of 2014, the smallest Li-ion cell was pin-shaped with a diameter of 3.5 mm and a weight of 0.6 g, made by Panasonic. A coin cell form factor is available for LiCoO2 cells, usually designated with a "LiR" prefix.
Office of the Secretary of State Military Secretary's Department (1870–1964) Department of the Parliamentary Under-Secretary for War Directorate-General of Lands (?–1923) Directorate of Lands (from 1923) Directorate-General of the Territorial and Volunteer Forces (?–1921) Directorate-General of the Territorial Army (from 1921) Central Department (Department of the Secretary) Department of the Chaplain-General Department of the Judge Advocate-General Publicity Section/Information Section Department of the Financial and Parliamentary Secretary (Finance Department) Directorate of Army Contracts (from 1924) Imperial General Staff Directorate of Military Intelligence (?–1922) Directorate of Military Operations (?–1922) Directorate of Military Operations and Intelligence (from 1922) Directorate of Military Training (from 1922) Directorate of Army Staff Duties Department of the Adjutant-General Directorate-General of Graves Registration and Enquiries (?–1921) Directorate-General of Army Medical Services Directorate of Mobilisation Directorate of Organisation Directorate of Army Personal Service Directorate of Prisoners of War (?–1921) Directorate of Recruiting and Organisation Department of the Quartermaster-General Directorate of Equipment and Ordnance Stores (?–1927) Directorate of Movements Directorate of Quartering Directorate of Remounts Directorate of Supplies and Transport Controller of Surplus Stores and Salvage Surveyor-General of Supply (?–1921) Directorate-General of Army Veterinary Services Directorate of Works (from 1927) Department of the Master-General of the Ordnance Directorate of Artillery Directorate of Factories Directorate of Fortifications and Works (?–1927) Directorate of Ordnance Services (from 1927) Chief Technical Examiner for Works Services Directorate of Military Aeronautics (1913–1918)
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.